IMPEDIMED LIMITED - Announcements

0.00%

4.5¢

Market Cap $91.34M

Technology Scientific & Technical Instruments

ImpediMed Limited is an Australia-based medical technology company. The Company uses... ImpediMed Limited is an Australia-based medical technology company. The Company uses bioimpedance spectroscopy (BIS) technology to generate data to maximize patient health. The Company designs and manufactures medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. The Company’s SOZO Digital Health Platform is a Food and Drug Administration (FDA)-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema. SOZO uses its BIS technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. Its product SFB7 measures fluid status and tissue composition for clinical and research applications. Its ImpediVET is a single-channel, tetrapolar bioimpedance spectroscopy (BIS) device that measures fluid status and tissue composition for veterinary applications.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

IPD	Heart Failure 510(k) Application for SOZO Submitted to FDA	PRICE SENSITIVE	21/08/17	79.45KB	Share
IPD	US FDA 510(k) Clearance Issued for SOZO with L-Dex	PRICE SENSITIVE	14/08/17	75.36KB	Share
IPD	First patient enrolled in SOZO CHF Trial at Scripps Health	PRICE SENSITIVE	08/08/17	80.64KB	Share
IPD	Investor Presentation		24/07/17	2.43MB	Share
IPD	Appendix 4C - Quarter ended 30 June 2017	PRICE SENSITIVE	24/07/17	1.15MB	Share
IPD	ImpediMed Quarterly Results and Investor Conference Call		21/07/17	87.96KB	Share
IPD	IPD Submits FDA 510(k) Application for SOZO for Lymphoedema	PRICE SENSITIVE	17/07/17	76.9KB	Share
IPD	Ceasing to be a substantial holder from MQG		10/07/17	816.68KB	Share
IPD	L-Dex Recommended in Clinical Practice Guidelines	PRICE SENSITIVE	04/07/17	81.13KB	Share
IPD	Notification under section 708A(5)(e)		30/06/17	80.63KB	Share
IPD	Appendix 3B		30/06/17	187.83KB	Share
IPD	Becoming a substantial holder from MQG		29/06/17	850.31KB	Share
IPD	ImpediMed Commences Commercial Sales of SOZO		29/06/17	75.35KB	Share
IPD	Notification under section 708A(5)(e)		21/06/17	80.42KB	Share
IPD	Appendix 3B		21/06/17	185.96KB	Share
IPD	SOZO obtains CE Mark for Heart Failure Patient Monitoring	PRICE SENSITIVE	21/06/17	105.88KB	Share
IPD	Macquarie University Commences Lymphoedema Study Using Sozo	PRICE SENSITIVE	14/06/17	74.47KB	Share
IPD	Change of Director's Interest Notice		13/06/17	100.44KB	Share
IPD	L-Dex Study - Significant Reduction in Clinical Lymphoedema	PRICE SENSITIVE	18/05/17	96.47KB	Share
IPD	Appendix 3B		01/05/17	181.75KB	Share
IPD	Change in substantial holding		27/04/17	456.97KB	Share
IPD	March 2017 Quarter Results & Investor Conference Call	PRICE SENSITIVE	26/04/17	98.83KB	Share
IPD	Appendix 4C - Quarter Ended 31 March 2017	PRICE SENSITIVE	26/04/17	1.05MB	Share
IPD	Impedimed Quarterly Results and Investor Conference Call		24/04/17	79.37KB	Share
IPD	SOZO Shipped to Vanderbilt to Commence At-Home Study	PRICE SENSITIVE	24/04/17	78.6KB	Share
IPD	Initial Director's Interest Notice		10/04/17	87.44KB	Share
IPD	Board of Directors Appointment		10/04/17	76.51KB	Share
IPD	Investor Presentation		27/03/17	1.28MB	Share
IPD	Initial Director's Interest Notice		24/03/17	98.32KB	Share
IPD	Notification under section 708A(5)(e)		23/03/17	80.63KB	Share
IPD	Appendix 3B		23/03/17	196.15KB	Share
IPD	initial Director's Interest Notice		23/03/17	87.42KB	Share
IPD	Appointment of Non-Executive Directors		20/03/17	84.14KB	Share
IPD	Notification under section 708A(5)(e)		13/03/17	80.73KB	Share
IPD	Appendix 3B		13/03/17	196.08KB	Share
IPD	Placement of First SOZO Unit at Scripps Health	PRICE SENSITIVE	07/03/17	87.63KB	Share
IPD	Appendix 3B		07/03/17	198.12KB	Share
IPD	Press Release Half-Year Results		24/02/17	98.27KB	Share
IPD	Appendix 4D and Financial Report 31 December 2016	PRICE SENSITIVE	24/02/17	769.1KB	Share
IPD	Final Director's Interest Notice		06/02/17	98.48KB	Share
IPD	Change in substantial holding		02/02/17	148.46KB	Share
IPD	Appendix 4C - Quarter Ended 31 December 2016	PRICE SENSITIVE	31/01/17	1.14MB	Share
IPD	ImpediMed Quarterly Results & Investor Conference Call		30/01/17	76.89KB	Share
IPD	Director Retirement		17/01/17	65.35KB	Share
IPD	Appendix 3B		16/01/17	182.04KB	Share
IPD	Ceasing to be a substantial holder		20/12/16	157.57KB	Share
IPD	Notification under section 708A(5)(e)		16/12/16	87.62KB	Share
IPD	Appendix 3B		16/12/16	192.59KB	Share
IPD	Notification under section 708A(5)(e)		15/12/16	87.23KB	Share
IPD	Appendix 3B		15/12/16	191.03KB	Share
IPD	Notification under section 708A(5)(e)		13/12/16	87.72KB	Share
IPD	Appendix 3B		13/12/16	192.67KB	Share
IPD	Appendix 3B		28/11/16	209.19KB	Share
IPD	Notification under section 708A(5)(e)		28/11/16	87.93KB	Share
IPD	Becoming a substantial holder		23/11/16	595.82KB	Share
IPD	Change of Director's Interest Notice		21/11/16	112.33KB	Share
IPD	Appendix 3B		21/11/16	202.99KB	Share
IPD	Notification Under Section 708A(5)(e)		15/11/16	80.87KB	Share
IPD	Appendix 3B		15/11/16	196.8KB	Share
IPD	Results of Meeting		14/11/16	30.67KB	Share
IPD	Chairman's Address		14/11/16	122.66KB	Share
IPD	IPD Establishes European CHF Medical Advisory Board		14/11/16	86.38KB	Share
IPD	Ceasing to be a substantial holder		14/11/16	46.63KB	Share
IPD	Appendix 3B		11/11/16	188.07KB	Share
IPD	Annual General Meeting Presentation		10/11/16	5.04MB	Share
IPD	Change in substantial holding		09/11/16	376.49KB	Share
IPD	Appendix 3B-IPD.AX		31/10/16	186.91KB	Share
IPD	Appendix 4C - Quarter Ended 30 September 2016-IPD.AX	PRICE SENSITIVE	26/10/16	533.25KB	Share
IPD	Becoming a substantial holder-IPD.AX		18/10/16	1.74MB	Share
IPD	Mayo Clinic to use SOZO in Heart Failure Study-IPD.AX		18/10/16	76.17KB	Share
IPD	Notification under section 708A(5)(e)-IPD.AX		13/10/16	80.71KB	Share
IPD	Appendix 3B-IPD.AX		13/10/16	195.99KB	Share
IPD	2016 Annual Report-IPD.AX		13/10/16	8.44MB	Share
IPD	Notice of Annual General Meeting and Proxy Form-IPD.AX		13/10/16	955.63KB	Share
IPD	Change in substantial holding-IPD.AX		12/10/16	140.78KB	Share
IPD	Ceasing to be a substantial holder-IPD.AX		07/10/16	99.3KB	Share
IPD	Notification Under Section 708A(5)(e)-IPD.AX		30/09/16	96.17KB	Share
IPD	Appendix 3B-IPD.AX		30/09/16	196.37KB	Share
IPD	Notification Under Section 708A(5)(e)-IPD.AX		23/09/16	96.17KB	Share
IPD	Appendix 3B-IPD.AX		23/09/16	218.17KB	Share
IPD	Study on Efficacy of L-Dex in Routine Clinical Practice-IPD.AX	PRICE SENSITIVE	14/09/16	76.27KB	Share
IPD	Becoming a substantial holder-IPD.AX		12/09/16	121.89KB	Share
IPD	Notification under section 708A(5)(e)-IPD.AX		05/09/16	96.17KB	Share
IPD	Appendix 3B-IPD.AX		05/09/16	196.55KB	Share
IPD	Change in substantial holding-IPD.AX		01/09/16	183.4KB	Share
IPD	Appendix 4G and Corporate Governance Statement-IPD.AX		24/08/16	783.94KB	Share
IPD	Annual Financial Report 30 June 2016-IPD.AX		24/08/16	6.72MB	Share
IPD	Appendix 4E and Press Release-IPD.AX	PRICE SENSITIVE	24/08/16	319.62KB	Share
IPD	Becoming a substantial holder-IPD.AX		12/08/16	355.4KB	Share
IPD	SOZO Launched - First Product for Health and Wellness Market-IPD.AX	PRICE SENSITIVE	11/08/16	75.61KB	Share
IPD	Ceasing to be a substantial holder-IPD.AX		10/08/16	259.22KB	Share
IPD	Initial Director's Interest Notice-IPD.AX		10/08/16	87.8KB	Share
IPD	Final Director's Interest Notice-IPD.AX		10/08/16	99.61KB	Share
IPD	Scripps to use SOZO in Heart Failure Study-IPD.AX	PRICE SENSITIVE	10/08/16	71.42KB	Share
IPD	Final Director's Interest Notice-IPD.AX		09/08/16	100.54KB	Share
IPD	FDA Releases Important Information on Digital Health-IPD.AX		09/08/16	87.28KB	Share
IPD	Changes to Board of Directors-IPD.AX		08/08/16	87.41KB	Share
IPD	Appendix 3B-IPD.AX		03/08/16	203.19KB	Share
IPD	ImpediMed - Bioshares Biotech Summit 2016 Presentation-IPD.AX		29/07/16	14.41MB	Share
IPD	Appendix 4C - Quarter Ended 30 June 2016-IPD.AX	PRICE SENSITIVE	28/07/16	270.47KB	Share

IPD Heart Failure 510(k) Application for SOZO Submitted to FDA
21/08/17	PRICE SENSITIVE	79.45KB	Share
IPD US FDA 510(k) Clearance Issued for SOZO with L-Dex
14/08/17	PRICE SENSITIVE	75.36KB	Share
IPD First patient enrolled in SOZO CHF Trial at Scripps Health
08/08/17	PRICE SENSITIVE	80.64KB	Share
IPD Investor Presentation
24/07/17		2.43MB	Share
IPD Appendix 4C - Quarter ended 30 June 2017
24/07/17	PRICE SENSITIVE	1.15MB	Share
IPD ImpediMed Quarterly Results and Investor Conference Call
21/07/17		87.96KB	Share
IPD IPD Submits FDA 510(k) Application for SOZO for Lymphoedema
17/07/17	PRICE SENSITIVE	76.9KB	Share
IPD Ceasing to be a substantial holder from MQG
10/07/17		816.68KB	Share
IPD L-Dex Recommended in Clinical Practice Guidelines
04/07/17	PRICE SENSITIVE	81.13KB	Share
IPD Notification under section 708A(5)(e)
30/06/17		80.63KB	Share
IPD Appendix 3B
30/06/17		187.83KB	Share
IPD Becoming a substantial holder from MQG
29/06/17		850.31KB	Share
IPD ImpediMed Commences Commercial Sales of SOZO
29/06/17		75.35KB	Share
IPD Notification under section 708A(5)(e)
21/06/17		80.42KB	Share
IPD Appendix 3B
21/06/17		185.96KB	Share
IPD SOZO obtains CE Mark for Heart Failure Patient Monitoring
21/06/17	PRICE SENSITIVE	105.88KB	Share
IPD Macquarie University Commences Lymphoedema Study Using Sozo
14/06/17	PRICE SENSITIVE	74.47KB	Share
IPD Change of Director's Interest Notice
13/06/17		100.44KB	Share
IPD L-Dex Study - Significant Reduction in Clinical Lymphoedema
18/05/17	PRICE SENSITIVE	96.47KB	Share
IPD Appendix 3B
01/05/17		181.75KB	Share
IPD Change in substantial holding
27/04/17		456.97KB	Share
IPD March 2017 Quarter Results & Investor Conference Call
26/04/17	PRICE SENSITIVE	98.83KB	Share
IPD Appendix 4C - Quarter Ended 31 March 2017
26/04/17	PRICE SENSITIVE	1.05MB	Share
IPD Impedimed Quarterly Results and Investor Conference Call
24/04/17		79.37KB	Share
IPD SOZO Shipped to Vanderbilt to Commence At-Home Study
24/04/17	PRICE SENSITIVE	78.6KB	Share
IPD Initial Director's Interest Notice
10/04/17		87.44KB	Share
IPD Board of Directors Appointment
10/04/17		76.51KB	Share
IPD Investor Presentation
27/03/17		1.28MB	Share
IPD Initial Director's Interest Notice
24/03/17		98.32KB	Share
IPD Notification under section 708A(5)(e)
23/03/17		80.63KB	Share
IPD Appendix 3B
23/03/17		196.15KB	Share
IPD initial Director's Interest Notice
23/03/17		87.42KB	Share
IPD Appointment of Non-Executive Directors
20/03/17		84.14KB	Share
IPD Notification under section 708A(5)(e)
13/03/17		80.73KB	Share
IPD Appendix 3B
13/03/17		196.08KB	Share
IPD Placement of First SOZO Unit at Scripps Health
07/03/17	PRICE SENSITIVE	87.63KB	Share
IPD Appendix 3B
07/03/17		198.12KB	Share
IPD Press Release Half-Year Results
24/02/17		98.27KB	Share
IPD Appendix 4D and Financial Report 31 December 2016
24/02/17	PRICE SENSITIVE	769.1KB	Share
IPD Final Director's Interest Notice
06/02/17		98.48KB	Share
IPD Change in substantial holding
02/02/17		148.46KB	Share
IPD Appendix 4C - Quarter Ended 31 December 2016
31/01/17	PRICE SENSITIVE	1.14MB	Share
IPD ImpediMed Quarterly Results & Investor Conference Call
30/01/17		76.89KB	Share
IPD Director Retirement
17/01/17		65.35KB	Share
IPD Appendix 3B
16/01/17		182.04KB	Share
IPD Ceasing to be a substantial holder
20/12/16		157.57KB	Share
IPD Notification under section 708A(5)(e)
16/12/16		87.62KB	Share
IPD Appendix 3B
16/12/16		192.59KB	Share
IPD Notification under section 708A(5)(e)
15/12/16		87.23KB	Share
IPD Appendix 3B
15/12/16		191.03KB	Share
IPD Notification under section 708A(5)(e)
13/12/16		87.72KB	Share
IPD Appendix 3B
13/12/16		192.67KB	Share
IPD Appendix 3B
28/11/16		209.19KB	Share
IPD Notification under section 708A(5)(e)
28/11/16		87.93KB	Share
IPD Becoming a substantial holder
23/11/16		595.82KB	Share
IPD Change of Director's Interest Notice
21/11/16		112.33KB	Share
IPD Appendix 3B
21/11/16		202.99KB	Share
IPD Notification Under Section 708A(5)(e)
15/11/16		80.87KB	Share
IPD Appendix 3B
15/11/16		196.8KB	Share
IPD Results of Meeting
14/11/16		30.67KB	Share
IPD Chairman's Address
14/11/16		122.66KB	Share
IPD IPD Establishes European CHF Medical Advisory Board
14/11/16		86.38KB	Share
IPD Ceasing to be a substantial holder
14/11/16		46.63KB	Share
IPD Appendix 3B
11/11/16		188.07KB	Share
IPD Annual General Meeting Presentation
10/11/16		5.04MB	Share
IPD Change in substantial holding
09/11/16		376.49KB	Share
IPD Appendix 3B-IPD.AX
31/10/16		186.91KB	Share
IPD Appendix 4C - Quarter Ended 30 September 2016-IPD.AX
26/10/16	PRICE SENSITIVE	533.25KB	Share
IPD Becoming a substantial holder-IPD.AX
18/10/16		1.74MB	Share
IPD Mayo Clinic to use SOZO in Heart Failure Study-IPD.AX
18/10/16		76.17KB	Share
IPD Notification under section 708A(5)(e)-IPD.AX
13/10/16		80.71KB	Share
IPD Appendix 3B-IPD.AX
13/10/16		195.99KB	Share
IPD 2016 Annual Report-IPD.AX
13/10/16		8.44MB	Share
IPD Notice of Annual General Meeting and Proxy Form-IPD.AX
13/10/16		955.63KB	Share
IPD Change in substantial holding-IPD.AX
12/10/16		140.78KB	Share
IPD Ceasing to be a substantial holder-IPD.AX
07/10/16		99.3KB	Share
IPD Notification Under Section 708A(5)(e)-IPD.AX
30/09/16		96.17KB	Share
IPD Appendix 3B-IPD.AX
30/09/16		196.37KB	Share
IPD Notification Under Section 708A(5)(e)-IPD.AX
23/09/16		96.17KB	Share
IPD Appendix 3B-IPD.AX
23/09/16		218.17KB	Share
IPD Study on Efficacy of L-Dex in Routine Clinical Practice-IPD.AX
14/09/16	PRICE SENSITIVE	76.27KB	Share
IPD Becoming a substantial holder-IPD.AX
12/09/16		121.89KB	Share
IPD Notification under section 708A(5)(e)-IPD.AX
05/09/16		96.17KB	Share
IPD Appendix 3B-IPD.AX
05/09/16		196.55KB	Share
IPD Change in substantial holding-IPD.AX
01/09/16		183.4KB	Share
IPD Appendix 4G and Corporate Governance Statement-IPD.AX
24/08/16		783.94KB	Share
IPD Annual Financial Report 30 June 2016-IPD.AX
24/08/16		6.72MB	Share
IPD Appendix 4E and Press Release-IPD.AX
24/08/16	PRICE SENSITIVE	319.62KB	Share
IPD Becoming a substantial holder-IPD.AX
12/08/16		355.4KB	Share
IPD SOZO Launched - First Product for Health and Wellness Market-IPD.AX
11/08/16	PRICE SENSITIVE	75.61KB	Share
IPD Ceasing to be a substantial holder-IPD.AX
10/08/16		259.22KB	Share
IPD Initial Director's Interest Notice-IPD.AX
10/08/16		87.8KB	Share
IPD Final Director's Interest Notice-IPD.AX
10/08/16		99.61KB	Share
IPD Scripps to use SOZO in Heart Failure Study-IPD.AX
10/08/16	PRICE SENSITIVE	71.42KB	Share
IPD Final Director's Interest Notice-IPD.AX
09/08/16		100.54KB	Share
IPD FDA Releases Important Information on Digital Health-IPD.AX
09/08/16		87.28KB	Share
IPD Changes to Board of Directors-IPD.AX
08/08/16		87.41KB	Share
IPD Appendix 3B-IPD.AX
03/08/16		203.19KB	Share
IPD ImpediMed - Bioshares Biotech Summit 2016 Presentation-IPD.AX
29/07/16		14.41MB	Share
IPD Appendix 4C - Quarter Ended 30 June 2016-IPD.AX
28/07/16	PRICE SENSITIVE	270.47KB	Share

REFRESH

First 7 8 9 10 11

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 4.5¢		Change 0.000(0.00%)		Mkt cap ! $91.34M

Open	High	Low	Value	Volume
4.5¢	4.5¢	4.5¢	$9.215K	204.7K

Buyers (Bids)

No.	Vol.	Price($)
1	227204	4.4¢

Sellers (Offers)

Price($)	Vol.	No.
4.7¢	112547	2

View Market Depth

No.	Vol.	Price($)
1	227204	0.044
2	323255	0.043
1	25000	0.042
6	380000	0.040
4	235000	0.039

Price($)	Vol.	No.
0.047	112547	2
0.048	548129	2
0.050	70000	2
0.051	70000	2
0.052	243123	2

Last trade - 15.08pm 08/08/2025 (20 minute delay)

IPD (ASX) Chart

IMPEDIMED LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available